Following were the notable penny stock buzzers in the previous session on high volume. Keep an eye on these stocks this week.
If you are interested in nanocap stocks here is one you should look into
Sparta Commercial Services, Inc. (OTCMKTS: SRCO) a technology based financing company with subsidiaries in mobile app development, crypto payment gateways, and CBD, Through its CBD subsidiary, New World Health Brands, Inc. offers CBD products manufactured in the United States and have been tested by highly accredited state-of-the art agriculture testing laboratories to ensure consistent ingredients and proportions listed and do not contain pesticides or other contaminants. SRCO offers a full array of hemp-derived CBD products that include oils, topical, capsules, tablets, pet and livestock tinctures. Friday’s vote could be a catalyst for SRCO stock.
HUMBL, Inc. (OTCMKTS:HMBL) stock was in action in the previous trading session as the stock ended lower by 7.20% at $0.1109 with over 9.74 million shares traded hands, compared to its average volume of 11.53 million shares.
The company announced that it has reduced its debt balance by exchanging promissory notes for common stock. On March 28, 2022, HUMBL entered into exchange agreements with various noteholders. Pursuant to such agreements, HUMBL exchanged promissory notes representing $3,176,804.61 in outstanding debt obligations for 37,374,172 shares of common stock.
Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) stock was one of the notable active movers in previous trading session as the stock was ended up by 5.32% at $0.79 with over 3.73 million shares traded hands, compared to its average volume of 1.39 million shares.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer.
Kona Gold Beverage, Inc. (OTCMKTS:KGKG) stock continued to trend higher on Thursday. On Thursday, the stock was up 40% to $0.0168 with more than 68.29 million shares traded hands, compared to its average volume of 25.07 million shares.
The company announced the Company had revenues of over one million dollars in the first quarter of 2022. This marks the Company’s first quarter of one million dollars or more, which is a huge milestone and testament to the continued growth it’s experiencing. Kona Gold Beverages two subsidiaries, Kona Gold LLC and Gold Leaf Distribution LLC’s combined revenue broke the one-million-dollar mark in Q1.
Regen BioPharma, Inc. (OTCMKTS:RGBP) stock was one of the most active stock buzzers. The stock slid 4% to $0.0098 with over 137.74 million shares traded hands, compared to its average volume of 29.81 million shares.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
